花园生物：9月2日召开董事会会议

Company Overview - Garden Bio (SZ 300401) announced on September 2 that its 12th meeting of the 7th board of directors was held, where the agenda included the election of a director to represent the company in executing its affairs [1] Financial Performance - For the year 2024, Garden Bio's revenue composition is as follows: Vitamins account for 65.08% and the pharmaceutical manufacturing sector accounts for 34.92% [1] - As of the report date, Garden Bio has a market capitalization of 7.9 billion [1]